title: First case of allergy to nivolumab.
authors.affiliation: Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain. Electronic address: mercedessaenzgarcia@gmail.com.
authors.forename: Mercedes
authors.initials: M
authors.lastname: Sáenz de Santa María García
authors.affiliation: Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
authors.forename: Blanca
authors.initials: B
authors.lastname: Noguerado-Mellado
authors.affiliation: Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
authors.forename: Patricia
authors.initials: P
authors.lastname: Rojas-Pérez-Ezquerra
authors.affiliation: Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
authors.forename: Alicia
authors.initials: A
authors.lastname: Prieto-García
authors.affiliation: Research and Development Department, BIAL-Arístegui, Bilbao, Spain.
authors.forename: Borja
authors.initials: B
authors.lastname: Bartolomé-Zavala
authors.affiliation: Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Tornero
mesh_terms: D061605:Administration, Intravenous; D000485:Allergens / Q000627:therapeutic use; D000799:Angioedema; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D007073:Immunoglobulin E / Q000378:metabolism; D008113:Liver Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D000077594:Nivolumab / Q000009:adverse effects* / Q000627:therapeutic use; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D012074:Remission Induction; D012882:Skin Tests; D014581:Urticaria; D028761:Withholding Treatment
chemical_list: D000485:Allergens; D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab; D007073:Immunoglobulin E